Guest guest Posted May 22, 2006 Report Share Posted May 22, 2006 Hmmm, what I am getting from this is that if gentamycin therapy failed the first time, the patient is in deep doo-doo because now there are hypometabolic bacteria variants that are resistant to treatment. But I guess that in the cystic fibrosis patients there was no such previous exposure. Is this right? - Kate > " Osteomyelitis. Several investigators have shown that SCVs can often > be recovered from cultures of normal S. aureus strains that have been > exposed to gentamicin or other aminoglycosides24, 47, 59, 62, 63, 65, > 66, 93, 94, 95. ... Menadione- or haemin-auxotrophic S. aureus SCVs > were > recovered only from those patients who had previously been treated > with gentamicin-containing beads. Large and small colony types were > recovered from three of these patients, and therapy failed despite > using antimicrobials with in vitro activity against these isolates. > By contrast, ten other patients with normal S. aureus (and no > previous placement of gentamicin-containing beads) had no relapses of > osteomyelitis within more than 1 year of primary diagnosis after > active antibiotics were given. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 22, 2006 Report Share Posted May 22, 2006 This is very interesting, but why do I get the feeling we're screwed? I'm glad you're out of school, too. Now you can provide us with lots of juicy research. :-) penny " " <usenethod@...> wrote: > > The new review is here: > http://www.nature.com/nrmicro/journal/v4/n4/full/nrmicro1384.html > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 22, 2006 Report Share Posted May 22, 2006 > Hmmm, what I am getting from this is that if gentamycin therapy > failed the first time, the patient is in deep doo-doo because now > there are hypometabolic bacteria variants that are resistant to > treatment. But I guess that in the cystic fibrosis patients there was > no such previous exposure. Is this right? I think patients with serious CF get lots of abx treatments... I think at least some are on non-terminating treatment. Unless it said something about these particular CFers being abx-naive or newly-dxd my guess would be they had lots of abx history. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 22, 2006 Report Share Posted May 22, 2006 <pennyhoule@...> wrote: > > This is very interesting, but why do I get the feeling we're screwed? Ah well, no more screwed than we were before any of us studied SCVs or any of these other hairy phenomena. And fortunately alot of good can be done even with existing technology. On the other hand, its exciting that people like Ying Zhang at Hopkins have their minds on developing new drugs to bomb out low-metabolic TB bugs. Theres a fair amount of drug development in this area, and its possible they could hit an agent that would have broad applicability for our kind. Unfortunately, however, some of the particular strengths and weaknesses of Mtb may not correspond well with those of other species. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 22, 2006 Report Share Posted May 22, 2006 There's 2 battle fronts- the infectious agents and the one that makes the huge difference 'the damage to the body'. I get out there and I can tell that while ill my inflammation has seen many of my blood vessels really take a pounding- while out playing soccer you can feel the veins rip away from something the inflammation stuck them to ...So having infectious agents that work is only half the picture... I suppose another way to look at this other picture is to get some feedback on the endometreosis side.. > > > > This is very interesting, but why do I get the feeling we're screwed? > > > Ah well, no more screwed than we were before any of us studied SCVs or > any of these other hairy phenomena. > > And fortunately alot of good can be done even with existing technology. > On the other hand, its exciting that people like Ying Zhang at Hopkins > have their minds on developing new drugs to bomb out low-metabolic TB > bugs. Theres a fair amount of drug development in this area, and its > possible they could hit an agent that would have broad applicability > for our kind. Unfortunately, however, some of the particular strengths > and weaknesses of Mtb may not correspond well with those of other > species. > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 22, 2006 Report Share Posted May 22, 2006 Thanks for the bright spot. Yes, I'm always encouraged when someone is researching a way to combat these problems, which are SO maddening. It's like those old Tom & Jerry cartoons. The mouse pops up through a hole in the swiss cheese, the cat bops it on the head thinking he's got it, but then the mouse pops up through another hole and bops the cat even harder! :-) penny > > > > This is very interesting, but why do I get the feeling we're screwed? > > > Ah well, no more screwed than we were before any of us studied SCVs or > any of these other hairy phenomena. > > And fortunately alot of good can be done even with existing technology. > On the other hand, its exciting that people like Ying Zhang at Hopkins > have their minds on developing new drugs to bomb out low-metabolic TB > bugs. Theres a fair amount of drug development in this area, and its > possible they could hit an agent that would have broad applicability > for our kind. Unfortunately, however, some of the particular strengths > and weaknesses of Mtb may not correspond well with those of other > species. > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.